Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
For patients with both obesity and type 2 diabetes, retatrutides dual effect on weight and glycaemic control may represent a clinically superior option to existing diabetes treatments that produce little weight loss
Many women report improved mental clarity, reduced food noise, and a healthier relationship with eating when dosing is tailored to their physiology rather than driven by scale goals
Patients will only be able to access brand-name versions like Ozempic, Wegovy, or Mounjaro medications that have historically been expensive and difficult to obtain due to demand
Our priority is providing individualized, medically supervised care with ongoing monitoring and support throughout treatment
Tirzepatide (sold as Zepbound for weight loss) targets two of the three receptors that retatrutide hits and produces about 22.5% body weight loss
in rare instances, a person could develop pancreatitis
US$ 28.56
US$ 25.69
US$ 28.92
US$ 27.55
US$ 25.26
US$ 29.62
US$ 21.17
US$ 22.91
